Back to 
HighTower Advisors, LLC
HighTower Advisors, LLC
INO
Showing 0 of 21 quarters
Position history for HighTower Advisors, LLC's holdings in Inovio Pharmaceuticals, Inc.
No. HighTower Advisors exited its INO (Inovio Pharmaceuticals) position in Q4 2023. Its Q3 2023 13F listed 34,423 shares worth $13,000. HighTower Advisors already held INO in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.